196 related articles for article (PubMed ID: 1580284)
1. Antihypertensive efficacy and safety of perindopril in mild-to-moderate essential hypertension: results of a double-blind multicenter study versus atenolol.
Morgan TO; Louis WJ; MacDonald GJ; Conway EL; Bartholomeusz LC; Anderson AI; Cameron DP; Donnelly T; Frewin DB; Hooper MJ
Am J Med; 1992 Apr; 92(4B):73S-78S. PubMed ID: 1580284
[TBL] [Abstract][Full Text] [Related]
2. A double blind comparison of perindopril and atenolol in essential hypertension.
Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
[TBL] [Abstract][Full Text] [Related]
3. Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
Thurston H; Desche P
J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S45-9. PubMed ID: 1725202
[TBL] [Abstract][Full Text] [Related]
4. Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril.
Alcocer L; Campos C; Bahena JH; Nacaud A; Parra Carillo J; Calvo C; Weber C; Lerebours G; Mickalonis L; Villahermosa MT
Cardiovasc Drugs Ther; 1995 Jun; 9(3):431-6. PubMed ID: 8527353
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
Thurston H
Clin Exp Pharmacol Physiol Suppl; 1992; 19():67-71. PubMed ID: 1395119
[TBL] [Abstract][Full Text] [Related]
6. A double-blind comparison of perindopril and hydrochlorothiazide-amiloride in mild to moderate essential hypertension.
Andrejak M; Santoni JP; Carré A; Deruyttere M; Magometschnigg D; Gotzen R; Stumpe KO
Fundam Clin Pharmacol; 1991; 5(3):185-92. PubMed ID: 1682228
[TBL] [Abstract][Full Text] [Related]
7. Perindopril: first-line treatment for hypertension.
Zanchetti A; Desche P
Clin Exp Hypertens A; 1989; 11 Suppl 2():555-73. PubMed ID: 2691129
[TBL] [Abstract][Full Text] [Related]
8. First-line treatment in hypertension. Role of perindopril.
Zanchetti A
Drugs; 1990; 39 Suppl 1():71-5. PubMed ID: 2407495
[TBL] [Abstract][Full Text] [Related]
9. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.
Freytag F; Schelling A; Meinicke T; Deichsel G;
Clin Ther; 2001 Jan; 23(1):108-23. PubMed ID: 11219471
[TBL] [Abstract][Full Text] [Related]
11. A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS).
Stumpe KO; Overlack A
Am J Cardiol; 1993 Jun; 71(17):32E-37E. PubMed ID: 8328365
[TBL] [Abstract][Full Text] [Related]
12. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension.
Thybo NK; Stephens N; Cooper A; Aalkjaer C; Heagerty AM; Mulvany MJ
Hypertension; 1995 Apr; 25(4 Pt 1):474-81. PubMed ID: 7721386
[TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin-converting enzyme inhibition with perindopril and beta-blockade with atenolol on retinal blood flow in hypertensive diabetic subjects.
Patel V; Rassam SM; Chen HC; Jones M; Kohner EM
Metabolism; 1998 Dec; 47(12 Suppl 1):28-33. PubMed ID: 9867068
[TBL] [Abstract][Full Text] [Related]
14. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
15. Long-term acceptability of perindopril: European multicenter trial on 856 patients.
Degaute JP; Leeman M; Desche P
Am J Med; 1992 Apr; 92(4B):84S-90S. PubMed ID: 1580287
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive Effect and Tolerability of Perindopril in Indian Hypertensive and Type 2 Diabetic Patients: 1-Year Randomised, Double-Blind, Parallel Study vs Atenolol.
Seedat YK; Randeree IG
Clin Drug Investig; 1998; 16(3):229-40. PubMed ID: 18370544
[TBL] [Abstract][Full Text] [Related]
17. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
Letellier P; Overlack A; Agnes E; Desche P
J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
[TBL] [Abstract][Full Text] [Related]
18. Captopril versus perindopril: a double blind study in essential hypertension.
Lees KR; Reid JL; Scott MG; Hosie J; Herpin D; Santoni JP
J Hum Hypertens; 1989 Feb; 3(1):17-22. PubMed ID: 2657055
[TBL] [Abstract][Full Text] [Related]
19. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S27-30. PubMed ID: 1726002
[TBL] [Abstract][Full Text] [Related]
20. A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertension.
Frishman WH; Brobyn R; Brown RD; Johnson BF; Reeves RL; Wombolt DG
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S103-6. PubMed ID: 2467116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
